4.4 Article

β-spectrinBari: a truncated β-chain responsible for dominant hereditary spherocytosis

Journal

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
Volume 94, Issue 12, Pages 1753-1757

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2009.010124

Keywords

beta-spectrin; truncated beta-chain; hereditary spherocytosis

Categories

Funding

  1. Progetti di Rilevante Interesse Nazionale (PRIN)
  2. Agenzia Italiana del Farmaco (AIFA)
  3. Regione Campania [LR 5/02]

Ask authors/readers for more resources

We describe a beta-spectrin variant, named beta-spectrin Bari, characterized by a truncated chain and associated with hereditary spherocytosis. The clinical phenotype consists of a moderately severe hemolytic anemia, splenomegaly, and spherocytes and acanthocytes in the blood smear. The occurrence of the truncated protein, that represents about 8% of the total beta-spectrin occurring on the membrane, results in a marked spectrin deficiency. The altered protein is due to a single point mutation at position -2 (A -> G) of the acceptor splice site of intron 16 leading to an aberrant beta-spectrin message skipping exons 16 and 17 indistinguishable from that reported for beta-spectrin Winston-Salem. We provide evidence that the mutated gene is transcribed but its mRNA is less abundant than either its normal counterpart or beta-spectrin Winston-Salem mRNA. Our findings are an example of how mutations in different splice sites, although causing the same truncating effect, result in clearly different clinical pictures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Hematology

Nobel prize in physiology or medicine 2021, receptors for temperature and touch: Implications for hematology

Immacolata Andolfo, Seth L. Alper, Achille Iolascon

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Article Hematology

Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells

Alessandra Di Paola, Giuseppe Palumbo, Chiara Tortora, Maura Argenziano, Marialuigia Catanoso, Caterina Di Leva, Giulia Ceglie, Silverio Perrotta, Franco Locatelli, Francesca Rossi

Summary: ITP is an autoimmune disease characterized by platelet destruction, while MSCs play a crucial role in modulating immune and inflammatory processes. ELT, a thrombopoietin receptor agonist, can restore and promote the activity of ITP-MSCs by modulating iron metabolism, exhibiting immunomodulating properties.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Genetics & Heredity

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients

Stefania Mantovani, Sergio Daga, Chiara Fallerini, Margherita Baldassarri, Elisa Benetti, Nicola Picchiotti, Francesca Fava, Anna Galli, Silvia Zibellini, Mirella Bruttini, Maria Palmieri, Susanna Croci, Sara Amitrano, Diana Alaverdian, Katia Capitani, Simone Furini, Francesca Mari, Ilaria Meloni, Elisa Frullanti, Mario U. Mondelli, Alessandra Renieri

Summary: TLR7 variants in male patients lead to impaired immune response to viruses like SARS-CoV-2, resulting in severe COVID-19. These variants cause significant damage to the TLR7 signaling pathway and hinder the type I and II interferon responses.

GENES AND IMMUNITY (2022)

Article Genetics & Heredity

Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

Chiara Fallerini, Nicola Picchiotti, Margherita Baldassarri, Kristina Zguro, Sergio Daga, Francesca Fava, Elisa Benetti, Sara Amitrano, Mirella Bruttini, Maria Palmieril, Susanna Croci, Mirjam Lista, Giada Beligni, Floriana Valentino, Ilaria Meloni, Marco Tanfoni, Francesca Minnai, Francesca Colombo, Enrico Cabri, Maddalena Fratelli, Chiara Gabbi, Stefania Mantovani, Elisa Frullanti, Marco Gori, Francis P. Crawley, Guillaume Butler-Laporte, Brent Richards, Hugo Zeberg, Miklos Lipcsey, Michael Hultstrom, Kerstin U. Ludwig, Eva C. Schulte, Erola Pairo-Castineira, John Kenneth Baillie, Axel Schmidt, Robert Frithiof, Francesca Mari, Alessandra Renieri, Simone Furini

Summary: The study developed a machine-learning model using common and rare exonic variants to predict COVID-19 severity. By selecting key Boolean features and combining them into an Integrated PolyGenic Score, the model offers insights into the genetic contribution to disease severity. A quarter of the selected genes are sex-specific, and pathway analysis highlighted the multi-organ nature of COVID-19 severity. This model could potentially aid in diagnostics, therapeutics, and disease management at the bedside.

HUMAN GENETICS (2022)

Article Gastroenterology & Hepatology

Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease

Chiara Tortora, Alessandra Di Paola, Mara Creoli, Maura Argenziano, Massimo Martinelli, Erasmo Miele, Francesca Rossi, Caterina Strisciuglio

Summary: By studying the roles of CB2 and TRPV1 receptors in pediatric IBD-related osteoporosis, it was found that their stimulation can reduce OC overactivity induced by iron, providing new insights into the pathogenesis of bone resorption associated with IBD.

INFLAMMATORY BOWEL DISEASES (2022)

Article Oncology

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience

Alberto Garaventa, Stefano Parodi, Giulia Guerrini, Piero Farruggia, Alessandra Sala, Marta Pillon, Salvatore Buffardi, Francesca Rossi, Maurizio Bianchi, Marco Zecca, Luciana Vinti, Elena Facchini, Tommaso Casini, Sayla Bernasconi, Loredana Amoroso, Salvatore D'Amico, Massimo Provenzi, Raffaela De Santis, Antonella Sau, Paola Muggeo, Rosa Maria Mura, Riccardo Haupt, Maurizio Mascarin, Roberta Burnelli

Summary: The study focused on identifying prognostic factors and tailoring salvage therapy for children and adolescents with relapsed or progressive classical Hodgkin's lymphoma. Over a 10-year follow-up period, the overall survival was 65.3% and the event-free survival was 53.3%. Progressive disease, advanced stage, and ≥5 involved sites were associated with significantly poorer outcomes.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Effects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Celiac Disease

Chiara Tortora, Alessandra Di Paola, Maura Argenziano, Mara Creoli, Maria Maddalena Marrapodi, Sabrina Cenni, Carlo Tolone, Francesca Rossi, Caterina Strisciuglio

Summary: Celiac Disease is an autoimmune disease triggered by gluten exposure, and recent studies have shown the involvement of macrophages in its pathogenesis. The Cannabinoid Receptor 2 (CB2) could be a potential therapeutic target for Celiac Disease by regulating macrophage polarization and preventing mucosal barrier damage.

BIOMEDICINES (2022)

Article Pediatrics

Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease

Caterina Strisciuglio, Mara Creoli, Chiara Tortora, Massimo Martinelli, Erasmo Miele, Salvatore Paino, Livio Luongo, Francesca Rossi

Summary: This study analyzed the expression of CB2 and factors associated with IBD inflammatory pathways in intestinal biopsies of pediatric CD and UC patients. The results showed an upregulation of CB2 in pediatric IBD, which could have implications for drug discovery.

PEDIATRIC RESEARCH (2023)

Article Genetics & Heredity

A Novel Variant in RAD21 in Cornelia De Lange Syndrome Type 4: Case Report and Bioinformatic Analysis

Alessandro De Falco, Daniele De Brasi, Matteo Della Monica, Claudia Cesario, Stefano Petrocchi, Antonio Novelli, Giuseppe D'Alterio, Achille Iolascon, Mario Capasso, Carmelo Piscopo

Summary: Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder that affects multiple organs. This study presents clinical and genetic findings of a patient with CdLS type 4, a syndrome that has been rarely described before. The patient exhibited previously reported clinical features of CdLS type 4 as well as additional symptoms not mentioned previously. The novel genetic variant found in this patient suggests its pathogenicity. This report provides valuable insights for counseling future CdLS type 4 cases.

GENES (2023)

Article Hematology

Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations

Immacolata Andolfo, Vittoria Monaco, Flora Cozzolino, Barbara Eleni Rosato, Roberta Marra, Vincenza Cerbone, Valeria Maria Pinto, Gian Luca Forni, Sule Unal, Achille Iolascon, Maria Monti, Roberta Russo

BLOOD ADVANCES (2023)

Letter Hematology

Coinheritance of PIEZO1 variants and multi-locus red blood cell defects account for the symptomatic phenotype in beta-thalassemia carriers

Valeria Maria Pinto, Roberta Russo, Sabrina Quintino, Barbara Eleni Rosato, Roberta Marra, Federica Del Giudice, Massimo Mogni, Massimo Maffei, Achille Iolascon, Gian Luca Forni, Immacolata Andolfo

Summary: This study provides an overview of the workflow and includes some examples of the achieved results.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Article Biochemistry & Molecular Biology

CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy

Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, Chiara Tortora, Maria Maddalena Marrapodi, Giulia Giliberti, Domenico Roberti, Maria Caterina Pace, Francesca Rossi

Summary: Duchenne Muscular Dystrophy (DMD) is a severe disease caused by a mutation in the DMD gene, leading to muscular degeneration and secondary complications. The main therapy for DMD is corticosteroids, but the side effects call for safer alternatives. Macrophages, immune cells expressing the CB2 receptor, have been suggested as a target for anti-inflammatory treatment. In this study, the CB2 receptor agonist JWH-133 was found to have a beneficial effect by reducing pro-inflammatory cytokines and promoting anti-inflammatory macrophage phenotype in DMD-associated macrophages.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Genetics & Heredity

New Insights in 9q21.13 Microdeletion Syndrome: Genotype-Phenotype Correlation of 28 Patients

Alessandro De Falco, Achille Iolascon, Flora Ascione, Carmelo Piscopo

Summary: The use of array comparative genomic hybridization (array-CGH) has identified new microdeletion/microduplication syndromes, including the 9q21.13 microdeletion syndrome. This syndrome involves the loss of a specific genomic region and is associated with developmental delay, intellectual disability, autistic behavior, seizures, facial dysmorphism, myopia, and previously unreported brain anomalies. A study of 28 patients, including our case, allowed for the classification and analysis of candidate genes, as well as the correlation between genotype and phenotype. These findings provide a better understanding of the syndromic spectrum of 9q21.13 microdeletion syndrome and suggest the need for regular ophthalmological and neurological monitoring.

GENES (2023)

Review Oncology

Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype-Phenotype Correlations

Cristina Peduto, Mariateresa Zanobio, Vincenzo Nigro, Silverio Perrotta, Giulio Piluso, Claudia Santoro

Summary: In recent years, there has been an increase in the description of genotype-phenotype correlations for neurofibromatosis type 1 (NF1), which affects the clinical follow-up of patients, especially children. The use of molecular diagnosis, facilitated by next generation sequencing technology, allows for early confirmation of clinical diagnosis, even in cases with atypical presentation or overlapping conditions. This article reviews the main clinical characteristics and complications of NF1, particularly in children, and discusses the genotype-phenotype associations that impact genetic counseling and prognosis. Molecular diagnosis is crucial for confirming clinical diagnoses, especially with recently revised diagnostic criteria, and for early identification of genotypes associated with specific phenotypes.

CANCERS (2023)

Article Pediatrics

Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior

Nicola Davide Cavallo, Gianpaolo Maggi, Francesco Ferraiuolo, Anna Sorrentino, Silverio Perrotta, Marco Carotenuto, Gabriella Santangelo, Claudia Santoro

Summary: This study examined the prevalence of bullying/cyberbullying behaviors and victimization behaviors in children and adolescents with NF1. The findings show that victimization behaviors were more common than bullying/cyberbullying ones. Participants also reported depressive and anxiety symptoms, reduced self-esteem, and low psychosocial quality of life, with females experiencing more severe effects. Reduced self-esteem was associated with more visible NF1 symptoms, and victimization behaviors mediated the relationship between anxiety and psychosocial quality of life. These results highlight the importance of a multidisciplinary approach in the diagnosis and treatment of NF1.

CHILDREN-BASEL (2023)

No Data Available